O'Byrne Jason 4
4 · Caribou Biosciences, Inc. · Filed Dec 21, 2021
Insider Transaction Report
Form 4
O'Byrne Jason
Chief Financial Officer
Transactions
- Award
Option to purchase Common Stock
2021-12-20+147,000→ 147,000 totalExercise: $15.16Exp: 2031-12-19→ Common Stock (147,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.